HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-DEC-15 5F20 TITLE STRUCTURE OF TYK2 WITH INHIBITOR 4: 3-AZANYL-5-(2-METHYLPHENYL)-7-(1- TITLE 2 METHYLPYRAZOL-3-YL)-1~{H}-PYRAZOLO[4,3-C]PYRIDIN-4-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2; COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.10.2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TYK2; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.J.SKENE REVDAT 4 06-MAR-24 5F20 1 JRNL REMARK REVDAT 3 10-FEB-16 5F20 1 JRNL REVDAT 2 20-JAN-16 5F20 1 JRNL REVDAT 1 13-JAN-16 5F20 0 JRNL AUTH T.YOGO,H.NAGAMIYA,M.SETO,S.SASAKI,H.SHIH-CHUNG,Y.OHBA, JRNL AUTH 2 N.TOKUNAGA,G.N.LEE,C.Y.RHIM,C.H.YOON,S.Y.CHO,R.SKENE, JRNL AUTH 3 S.YAMAMOTO,Y.SATOU,M.KUNO,T.MIYAZAKI,H.NAKAGAWA,A.OKABE, JRNL AUTH 4 S.MARUI,K.ASO,M.YOSHIDA JRNL TITL STRUCTURE-BASED DESIGN AND SYNTHESIS OF JRNL TITL 2 3-AMINO-1,5-DIHYDRO-4H-PYRAZOLOPYRIDIN-4-ONE DERIVATIVES AS JRNL TITL 3 TYROSINE KINASE 2 INHIBITORS. JRNL REF J.MED.CHEM. V. 59 733 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26701356 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01857 REMARK 2 REMARK 2 RESOLUTION. 2.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 7505 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.288 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 359 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2244 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 31 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 96.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.76000 REMARK 3 B22 (A**2) : 4.76000 REMARK 3 B33 (A**2) : -7.13000 REMARK 3 B12 (A**2) : 2.38000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.479 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.463 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 54.370 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5F20 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-DEC-15. REMARK 100 THE DEPOSITION ID IS D_1000215868. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-DEC-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8088 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 8.800 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.2 REMARK 200 DATA REDUNDANCY IN SHELL : 8.90 REMARK 200 R MERGE FOR SHELL (I) : 0.78200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.1.4, PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 5000 MME, AND 100 MM SODIUM REMARK 280 CITRATE (PH 6.0), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 159.11467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 318.22933 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 238.67200 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 397.78667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 79.55733 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 159.11467 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 318.22933 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 397.78667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 238.67200 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 79.55733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 882 REMARK 465 GLY A 883 REMARK 465 SER A 884 REMARK 465 PRO A 885 REMARK 465 ALA A 886 REMARK 465 SER A 887 REMARK 465 ALA A 934 REMARK 465 ASP A 935 REMARK 465 CYS A 936 REMARK 465 GLY A 937 REMARK 465 PRO A 938 REMARK 465 GLN A 939 REMARK 465 HIS A 940 REMARK 465 ARG A 941 REMARK 465 SER A 942 REMARK 465 GLN A 969 REMARK 465 GLY A 970 REMARK 465 GLU A 971 REMARK 465 LYS A 972 REMARK 465 ILE A 1114 REMARK 465 ALA A 1115 REMARK 465 HIS A 1177 REMARK 465 HIS A 1178 REMARK 465 HIS A 1179 REMARK 465 HIS A 1180 REMARK 465 HIS A 1181 REMARK 465 HIS A 1182 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 900 -76.53 -112.94 REMARK 500 THR A 923 -34.02 -155.43 REMARK 500 CYS A 965 -156.80 -135.04 REMARK 500 PRO A 991 7.94 -65.03 REMARK 500 HIS A1018 38.67 74.93 REMARK 500 ARG A1022 -0.57 65.78 REMARK 500 ASN A1023 23.83 -144.74 REMARK 500 ASP A1032 -156.70 -93.58 REMARK 500 ASP A1041 78.87 31.35 REMARK 500 ASP A1060 -61.98 -95.49 REMARK 500 PRO A1064 65.40 -66.89 REMARK 500 CYS A1098 15.35 57.19 REMARK 500 SER A1101 34.00 -82.24 REMARK 500 GLN A1102 -16.16 -151.20 REMARK 500 SER A1103 151.79 -47.71 REMARK 500 ILE A1112 -83.86 -89.81 REMARK 500 LYS A1139 -5.70 70.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5U4 A 1200 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5F1Z RELATED DB: PDB DBREF 5F20 A 884 1176 UNP P29597 TYK2_HUMAN 884 1176 SEQADV 5F20 MET A 882 UNP P29597 INITIATING METHIONINE SEQADV 5F20 GLY A 883 UNP P29597 EXPRESSION TAG SEQADV 5F20 SER A 1016 UNP P29597 ALA 1016 CONFLICT SEQADV 5F20 ASN A 1023 UNP P29597 ASP 1023 CONFLICT SEQADV 5F20 HIS A 1177 UNP P29597 EXPRESSION TAG SEQADV 5F20 HIS A 1178 UNP P29597 EXPRESSION TAG SEQADV 5F20 HIS A 1179 UNP P29597 EXPRESSION TAG SEQADV 5F20 HIS A 1180 UNP P29597 EXPRESSION TAG SEQADV 5F20 HIS A 1181 UNP P29597 EXPRESSION TAG SEQADV 5F20 HIS A 1182 UNP P29597 EXPRESSION TAG SEQRES 1 A 301 MET GLY SER PRO ALA SER ASP PRO THR VAL PHE HIS LYS SEQRES 2 A 301 ARG TYR LEU LYS LYS ILE ARG ASP LEU GLY GLU GLY HIS SEQRES 3 A 301 PHE GLY LYS VAL SER LEU TYR CYS TYR ASP PRO THR ASN SEQRES 4 A 301 ASP GLY THR GLY GLU MET VAL ALA VAL LYS ALA LEU LYS SEQRES 5 A 301 ALA ASP CYS GLY PRO GLN HIS ARG SER GLY TRP LYS GLN SEQRES 6 A 301 GLU ILE ASP ILE LEU ARG THR LEU TYR HIS GLU HIS ILE SEQRES 7 A 301 ILE LYS TYR LYS GLY CYS CYS GLU ASP GLN GLY GLU LYS SEQRES 8 A 301 SER LEU GLN LEU VAL MET GLU TYR VAL PRO LEU GLY SER SEQRES 9 A 301 LEU ARG ASP TYR LEU PRO ARG HIS SER ILE GLY LEU ALA SEQRES 10 A 301 GLN LEU LEU LEU PHE ALA GLN GLN ILE CYS GLU GLY MET SEQRES 11 A 301 ALA TYR LEU HIS SER GLN HIS TYR ILE HIS ARG ASN LEU SEQRES 12 A 301 ALA ALA ARG ASN VAL LEU LEU ASP ASN ASP ARG LEU VAL SEQRES 13 A 301 LYS ILE GLY ASP PHE GLY LEU ALA LYS ALA VAL PRO GLU SEQRES 14 A 301 GLY HIS GLU TYR TYR ARG VAL ARG GLU ASP GLY ASP SER SEQRES 15 A 301 PRO VAL PHE TRP TYR ALA PRO GLU CYS LEU LYS GLU TYR SEQRES 16 A 301 LYS PHE TYR TYR ALA SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 301 THR LEU TYR GLU LEU LEU THR HIS CYS ASP SER SER GLN SEQRES 18 A 301 SER PRO PRO THR LYS PHE LEU GLU LEU ILE GLY ILE ALA SEQRES 19 A 301 GLN GLY GLN MET THR VAL LEU ARG LEU THR GLU LEU LEU SEQRES 20 A 301 GLU ARG GLY GLU ARG LEU PRO ARG PRO ASP LYS CYS PRO SEQRES 21 A 301 CYS GLU VAL TYR HIS LEU MET LYS ASN CYS TRP GLU THR SEQRES 22 A 301 GLU ALA SER PHE ARG PRO THR PHE GLU ASN LEU ILE PRO SEQRES 23 A 301 ILE LEU LYS THR VAL HIS GLU LYS TYR HIS HIS HIS HIS SEQRES 24 A 301 HIS HIS HET 5U4 A1200 24 HETNAM 5U4 3-AZANYL-5-(2-METHYLPHENYL)-7-(1-METHYLPYRAZOL-3-YL)- HETNAM 2 5U4 1~{H}-PYRAZOLO[4,3-C]PYRIDIN-4-ONE FORMUL 2 5U4 C17 H16 N6 O FORMUL 3 HOH *31(H2 O) HELIX 1 AA1 LYS A 945 ARG A 952 1 8 HELIX 2 AA2 SER A 985 LEU A 990 1 6 HELIX 3 AA3 PRO A 991 HIS A 993 5 3 HELIX 4 AA4 GLY A 996 GLN A 1017 1 22 HELIX 5 AA5 ALA A 1025 ARG A 1027 5 3 HELIX 6 AA6 PRO A 1064 TYR A 1068 5 5 HELIX 7 AA7 ALA A 1069 TYR A 1076 1 8 HELIX 8 AA8 TYR A 1079 THR A 1096 1 18 HELIX 9 AA9 SER A 1103 GLY A 1113 1 11 HELIX 10 AB1 MET A 1119 GLY A 1131 1 13 HELIX 11 AB2 PRO A 1141 TRP A 1152 1 12 HELIX 12 AB3 GLU A 1155 ARG A 1159 5 5 HELIX 13 AB4 THR A 1161 GLU A 1174 1 14 SHEET 1 AA1 5 LEU A 897 GLU A 905 0 SHEET 2 AA1 5 GLY A 909 TYR A 916 -1 O VAL A 911 N LEU A 903 SHEET 3 AA1 5 GLU A 925 LEU A 932 -1 O VAL A 927 N TYR A 914 SHEET 4 AA1 5 GLN A 975 GLU A 979 -1 O MET A 978 N ALA A 928 SHEET 5 AA1 5 TYR A 962 GLY A 964 -1 N GLY A 964 O VAL A 977 SHEET 1 AA2 2 TYR A1019 ILE A1020 0 SHEET 2 AA2 2 LYS A1046 ALA A1047 -1 O LYS A1046 N ILE A1020 SHEET 1 AA3 2 VAL A1029 LEU A1031 0 SHEET 2 AA3 2 VAL A1037 ILE A1039 -1 O LYS A1038 N LEU A1030 SITE 1 AC1 12 ARG A 901 LEU A 903 GLU A 905 GLY A 906 SITE 2 AC1 12 ILE A 960 GLU A 979 TYR A 980 VAL A 981 SITE 3 AC1 12 PRO A 982 GLY A 984 ARG A1027 LEU A1030 CRYST1 48.332 48.332 477.344 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020690 0.011946 0.000000 0.00000 SCALE2 0.000000 0.023891 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002095 0.00000